Acumen Pharmaceuticals, Inc. (ABOS)

Acumen Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	30.16	35.63	66.89	130.1	122.16	43.78
Short-Term Investments	118.99	135.93	176.64	47.5	72.08	-
Cash & Short-Term Investments	149.15	171.56	243.52	177.61	194.24	43.78
Cash Growth	-40.93%	-29.55%	37.11%	-8.56%	343.70%	568.15%
Accounts Receivable	-	-	-	-	-	0.11
Other Receivables	0.71	0.63	0.4	0.11	0.1	-
Receivables	0.71	0.63	0.4	0.11	0.1	0.11
Inventory	-	0.16	0.1	0.2	0.08	0.09
Prepaid Expenses	0.48	0.86	0.81	1.11	1.51	0.01
Other Current Assets	4.61	5.1	1.79	1.31	2.73	0.45
Total Current Assets	154.95	178.31	246.62	180.33	198.66	44.43
Property, Plant & Equipment	0.37	0.34	0.5	0.27	0.04	-
Long-Term Investments	48.8	59.97	62.55	15.84	31.62	-
Other Long-Term Assets	0.31	0.38	0.45	0.15	0.01	-
Total Assets	204.48	238.99	310.13	196.59	230.33	44.43
Accounts Payable	1.06	5.65	1.38	1.64	1.09	0.53
Accrued Expenses	17.7	21.6	10.51	5.94	3.86	0.33
Current Portion of Leases	0.14	0.13	0.87	0.11	-	-
Other Current Liabilities	0.42	0.23	0.21	0.13	0.2	5.5
Total Current Liabilities	19.32	27.61	12.97	7.81	5.15	6.37
Long-Term Debt	29.53	29.42	29.9	-	-	-
Long-Term Leases	0.11	0.15	0.28	-	-	-
Total Liabilities	48.96	57.18	43.15	7.81	5.15	6.37
Common Stock	0.01	0.01	0.01	0	0	-
Additional Paid-In Capital	509.42	506.99	489.45	359.95	352.98	8.37
Retained Earnings	-353.92	-325.13	-222.8	-170.43	-127.57	-26.97
Comprehensive Income & Other	0.02	-0.05	0.31	-0.75	-0.23	-
Total Common Equity	155.52	181.82	266.97	188.78	225.18	-18.59
Shareholders' Equity	155.52	181.82	266.97	188.78	225.18	38.06
Total Liabilities & Equity	204.48	238.99	310.13	196.59	230.33	44.43
Total Debt	29.78	29.7	31.05	0.11	-	-
Net Cash (Debt)	168.16	201.82	275.03	193.34	225.86	43.78
Net Cash Growth	-36.79%	-26.62%	42.25%	-14.40%	415.92%	568.15%
Net Cash Per Share	2.79	3.36	5.66	4.76	11.26	104.45
Filing Date Shares Outstanding	60.57	60.57	60.08	41.03	40.47	0.42
Total Common Shares Outstanding	60.57	60.09	57.91	41.03	40.47	0.42
Working Capital	135.63	150.7	233.64	172.52	193.51	38.06
Book Value Per Share	2.57	3.03	4.61	4.60	5.56	-44.35
Tangible Book Value	155.47	181.82	266.97	188.78	225.18	-18.59
Tangible Book Value Per Share	2.57	3.03	4.61	4.60	5.56	-44.35

Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q